Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business listing upgrade

Eupraxia transfers to Nasdaq Global Select

Analysis based on 6 articles · First reported Sep 08, 2026 · Last updated Sep 08, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The transfer to a higher market tier may enhance the company's visibility and liquidity, potentially attracting more institutional investors. The announcement of conference participation could increase investor engagement and interest in the company's clinical programs.

Biotechnology Pharmaceuticals

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, announced that its common shares commenced trading on the Nasdaq Global Select Market, the highest tier of Nasdaq, effective September 8, 2026. The shares previously traded on the Nasdaq Capital Market and continue under the ticker symbol 'EPRX'. The company's listing on the Toronto Stock Exchange remains unchanged. Management will participate in upcoming investor conferences including Cantor Global Healthcare Conference, H.C. Wainwright 28th Annual Global Investment Conference, and Morgan Stanley 24th Annual Global Healthcare Conference. The transfer reflects the company's progress and growth, according to CFO Alex Rothwell.

100 Eupraxia Pharmaceuticals commenced trading Nasdaq
40 Eupraxia Pharmaceuticals announced participation
stock
The company upgraded its listing to the Nasdaq Global Select Market, signaling financial strength and growth, which may positively influence investor perception.
Importance 100.0 Sentiment 20.0
exch
As the exchange, Nasdaq benefits from hosting a growing biotech company on its premier market tier.
Importance 80.0 Sentiment 10.0
exch
The company's TSX listing remains unchanged, with no direct impact.
Importance 30.0 Sentiment 0.0
per
As CFO, he commented on the company's progress, but the event does not directly affect him.
Importance 20.0 Sentiment 0.0
priv
Hosting a conference where Eupraxia will present, potentially increasing its engagement with the company.
Importance 10.0 Sentiment 0.0
priv
Hosting a conference where Eupraxia will present, potentially increasing its engagement with the company.
Importance 10.0 Sentiment 0.0
stock
Hosting a conference where Eupraxia will have meetings, potentially increasing its engagement with the company.
Importance 10.0 Sentiment 0.0
per
Contact person for investor inquiries; no direct impact.
Importance 5.0 Sentiment 0.0
per
Media contact; no direct impact.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.